Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""Anticoagulants"" wg kryterium: Temat


Tytuł :
The effect of DOAC-Stop on several oral and parenteral anticoagulants.
Autorzy :
Riva N; Department of Pathology, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.
Vella K; Coagulation Medicine Laboratory, Department of Pathology, Mater Dei Hospital, Msida, Malta.
Hickey K; Sheffield Haemophilia and Thrombosis Centre, University of Sheffield, Sheffield, UK.
Gatt P; Clinical Perfusion Services, Mater Dei Hospital, Msida, Malta.
Grima C; Clinical Perfusion Services, Mater Dei Hospital, Msida, Malta.
Zammit D; Coagulation Medicine Laboratory, Department of Pathology, Mater Dei Hospital, Msida, Malta.
Ageno W; Department of Medicine and Surgery, University of Insubria, Varese, Italy.
Kitchen S; Sheffield Haemophilia and Thrombosis Centre, University of Sheffield, Sheffield, UK.
Makris M; Sheffield Haemophilia and Thrombosis Centre, University of Sheffield, Sheffield, UK.
Gatt A; Department of Pathology, Faculty of Medicine and Surgery, University of Malta, Msida, Malta.; Coagulation Medicine Laboratory, Department of Pathology, Mater Dei Hospital, Msida, Malta.
Pokaż więcej
Źródło :
International journal of laboratory hematology [Int J Lab Hematol] 2021 Aug; Vol. 43 (4), pp. O171-O175. Date of Electronic Publication: 2021 Feb 17.
Typ publikacji :
Letter
MeSH Terms :
Anticoagulants/*chemistry
Charcoal/*chemistry
Administration, Oral ; Adsorption ; Anticoagulants/administration & dosage ; Anticoagulants/blood ; Blood Coagulation Tests/methods ; Blood Coagulation Tests/standards ; Humans ; Parenteral Nutrition
Opinia redakcyjna
Tytuł :
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases.
Autorzy :
Rivera-Caravaca JM; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK.; Department of Cardiology, Hospital Clínico Universitario Virgen de La Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain.; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Harrison SL; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK.; Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
Buckley BJR; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK.; Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
Fazio-Eynullayeva E; TriNetX LLC., Cambridge, MA, USA.
Underhill P; TriNetX LLC., London, UK.
Marín F; Department of Cardiology, Hospital Clínico Universitario Virgen de La Arrixaca, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB-Arrixaca), CIBERCV, Murcia, Spain.
Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK. .; Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK. .; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. .
Pokaż więcej
Źródło :
Cardiovascular diabetology [Cardiovasc Diabetol] 2021 Sep 04; Vol. 20 (1), pp. 176. Date of Electronic Publication: 2021 Sep 04.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Ambulatory Care/*methods
Anticoagulants/*administration & dosage
COVID-19/*drug therapy
Heart Diseases/*drug therapy
Metabolic Diseases/*drug therapy
Vitamin K/*antagonists & inhibitors
Administration, Oral ; Aged ; Aged, 80 and over ; Anticoagulants/adverse effects ; COVID-19/diagnosis ; COVID-19/mortality ; Factor Xa Inhibitors/administration & dosage ; Female ; Follow-Up Studies ; Heart Diseases/diagnosis ; Heart Diseases/mortality ; Hemorrhage/chemically induced ; Hemorrhage/mortality ; Humans ; Intensive Care Units/trends ; Male ; Metabolic Diseases/diagnosis ; Metabolic Diseases/mortality ; Middle Aged ; Mortality/trends ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Global access to affordable direct oral anticoagulants.
Autorzy :
Neumann I; Department of Internal Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Schünemann HJ; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada.
Bero L; Center for Bioethics and Humanities, University of Colorado Anschutz Medical Campus, Aurora, United States of America.
Cooke G; Department of Infectious Diseases, Imperial College London, London, England.
Magrini N; Italian Medicines Agency, Rome, Italy.
Moja L; Secretariat of the Model List of Essential Medicines, Department of Essential Health Products and Standards, World Health Organization, Avenue Appia 20, 1211 Geneva 27, Switzerland.
Pokaż więcej
Źródło :
Bulletin of the World Health Organization [Bull World Health Organ] 2021 Sep 01; Vol. 99 (9), pp. 653-660. Date of Electronic Publication: 2021 Jun 01.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Costs*
Anticoagulants/*economics
Drugs, Essential/*supply & distribution
Drugs, Generic/*supply & distribution
Health Services Accessibility/*statistics & numerical data
Anticoagulants/administration & dosage ; Anticoagulants/therapeutic use ; Costs and Cost Analysis ; Drugs, Essential/economics ; Drugs, Generic/economics ; Health Care Costs ; Humans
Czasopismo naukowe
Tytuł :
Impact of the COVID-19 Pandemic on Global Anticoagulant Sales: A Cross-Sectional Analysis Across 39 Countries.
Autorzy :
Hernandez I; Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, 3609 Forbes Avenue, Room 103, Pittsburgh, PA, 15261, USA. .
Tadrous M; Women's College Hospital, Toronto, ON, Canada.
Magnani JW; Division of Cardiology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Guo J; Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, FL, USA.
Suda KJ; Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Pokaż więcej
Źródło :
American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2021 Sep; Vol. 21 (5), pp. 581-583. Date of Electronic Publication: 2021 Mar 26.
Typ publikacji :
Letter; Research Support, N.I.H., Extramural
MeSH Terms :
Anticoagulants*/economics
Anticoagulants*/pharmacology
COVID-19*/complications
COVID-19*/drug therapy
COVID-19*/epidemiology
Drug Costs*/statistics & numerical data
Drug Costs*/trends
Drug and Narcotic Control*/methods
Drug and Narcotic Control*/statistics & numerical data
Thrombosis*/etiology
Thrombosis*/prevention & control
Hospitalization/*economics
Global Health/economics ; Global Health/statistics & numerical data ; Hospitalization/statistics & numerical data ; Humans ; Marketing/methods ; Marketing/statistics & numerical data ; SARS-CoV-2
Raport
Tytuł :
[Anticoagulation in intensive care medicine].
Autorzy :
Möhnle P; Abteilung für Transfusionsmedizin, Zelltherapeutika und Hämostaseologie, Klinik für Anästhesiologie, LMU Klinikum München, Ziemssenstr. 1, 80336, München, Deutschland. .
Bruegel M; Institut für Laboratoriumsmedizin, LMU Klinikum München, München, Deutschland.
Spannagl M; Abteilung für Transfusionsmedizin, Zelltherapeutika und Hämostaseologie, Klinik für Anästhesiologie, LMU Klinikum München, Ziemssenstr. 1, 80336, München, Deutschland.
Pokaż więcej
Transliterated Title :
Antikoagulation in der Intensivmedizin.
Źródło :
Medizinische Klinik, Intensivmedizin und Notfallmedizin [Med Klin Intensivmed Notfmed] 2021 Sep; Vol. 116 (6), pp. 499-507. Date of Electronic Publication: 2021 Aug 25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anticoagulants*/adverse effects
Blood Coagulation Disorders*
Blood Coagulation ; Critical Care ; Hemorrhage/chemically induced ; Humans
Czasopismo naukowe
Tytuł :
Abelacimab for Prevention of Venous Thromboembolism.
Autorzy :
Verhamme P; From KU Leuven Department of Cardiovascular Sciences, Vascular Medicine and Hemostasis, Leuven, Belgium (P.V.); Anthos Therapeutics, Cambridge, MA (B.A.Y., J.S., D.B.); International Trial Expertise Advisory and Services (A.S.) and the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam (H.R.B.) - both in Amsterdam; Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City (G.E.R.); and the Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada (J.I.W.).
Yi BA; From KU Leuven Department of Cardiovascular Sciences, Vascular Medicine and Hemostasis, Leuven, Belgium (P.V.); Anthos Therapeutics, Cambridge, MA (B.A.Y., J.S., D.B.); International Trial Expertise Advisory and Services (A.S.) and the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam (H.R.B.) - both in Amsterdam; Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City (G.E.R.); and the Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada (J.I.W.).
Segers A; From KU Leuven Department of Cardiovascular Sciences, Vascular Medicine and Hemostasis, Leuven, Belgium (P.V.); Anthos Therapeutics, Cambridge, MA (B.A.Y., J.S., D.B.); International Trial Expertise Advisory and Services (A.S.) and the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam (H.R.B.) - both in Amsterdam; Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City (G.E.R.); and the Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada (J.I.W.).
Salter J; From KU Leuven Department of Cardiovascular Sciences, Vascular Medicine and Hemostasis, Leuven, Belgium (P.V.); Anthos Therapeutics, Cambridge, MA (B.A.Y., J.S., D.B.); International Trial Expertise Advisory and Services (A.S.) and the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam (H.R.B.) - both in Amsterdam; Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City (G.E.R.); and the Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada (J.I.W.).
Bloomfield D; From KU Leuven Department of Cardiovascular Sciences, Vascular Medicine and Hemostasis, Leuven, Belgium (P.V.); Anthos Therapeutics, Cambridge, MA (B.A.Y., J.S., D.B.); International Trial Expertise Advisory and Services (A.S.) and the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam (H.R.B.) - both in Amsterdam; Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City (G.E.R.); and the Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada (J.I.W.).
Büller HR; From KU Leuven Department of Cardiovascular Sciences, Vascular Medicine and Hemostasis, Leuven, Belgium (P.V.); Anthos Therapeutics, Cambridge, MA (B.A.Y., J.S., D.B.); International Trial Expertise Advisory and Services (A.S.) and the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam (H.R.B.) - both in Amsterdam; Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City (G.E.R.); and the Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada (J.I.W.).
Raskob GE; From KU Leuven Department of Cardiovascular Sciences, Vascular Medicine and Hemostasis, Leuven, Belgium (P.V.); Anthos Therapeutics, Cambridge, MA (B.A.Y., J.S., D.B.); International Trial Expertise Advisory and Services (A.S.) and the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam (H.R.B.) - both in Amsterdam; Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City (G.E.R.); and the Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada (J.I.W.).
Weitz JI; From KU Leuven Department of Cardiovascular Sciences, Vascular Medicine and Hemostasis, Leuven, Belgium (P.V.); Anthos Therapeutics, Cambridge, MA (B.A.Y., J.S., D.B.); International Trial Expertise Advisory and Services (A.S.) and the Department of Vascular Medicine, Academic Medical Center, University of Amsterdam (H.R.B.) - both in Amsterdam; Hudson College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City (G.E.R.); and the Thrombosis and Atherosclerosis Research Institute, McMaster University, Hamilton, ON, Canada (J.I.W.).
Pokaż więcej
Corporate Authors :
ANT-005 TKA Investigators
Źródło :
The New England journal of medicine [N Engl J Med] 2021 Aug 12; Vol. 385 (7), pp. 609-617. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms :
Arthroplasty, Replacement, Knee*
Anticoagulants/*therapeutic use
Enoxaparin/*therapeutic use
Factor XI/*antagonists & inhibitors
Postoperative Complications/*prevention & control
Venous Thromboembolism/*prevention & control
Adult ; Aged ; Aged, 80 and over ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Dose-Response Relationship, Drug ; Enoxaparin/adverse effects ; Factor XI/metabolism ; Female ; Hemorrhage/chemically induced ; Humans ; Infusions, Intravenous ; Injections, Subcutaneous ; Male ; Middle Aged ; Partial Thromboplastin Time
Czasopismo naukowe
Tytuł :
Short- and Long-term Health Care Resource Utilization and Costs Following Intracerebral Hemorrhage.
Autorzy :
Fernando SM; From the Division of Critical Care (S.M.F., S.W.E., K.K.), Department of Medicine, and Department of Emergency Medicine (S.M.F.), University of Ottawa; ICES (D.Q., R.T., M.M.S., D.C.S., P.T.), Toronto; Clinical Epidemiology Program (D.Q., R.T., D.D., M.M.S., S.W.E., P.T., K.K.), Ottawa Hospital Research Institute; School of Epidemiology and Public Health (D.Q., D.D., M.M.S., S.W.E., P.T.), University of Ottawa; Bruyère Research Institute (D.Q., P.T.); Division of Palliative Care (D.Q., P.T., K.K.), Department of Medicine, Division of Neurology (D.D.), Department of Medicine, and Division of Nephrology (M.M.S.), Department of Medicine, University of Ottawa, Ontario; Calgary Stroke Program (E.E.S., M.D.H.), Hotchkiss Brain Institute, and Department of Clinical Neurosciences (E.E.S., M.D.H.), Cumming School of Medicine, University of Calgary, Alberta; Interdepartmental Division of Critical Care Medicine (V.A.M., D.C.S.), University of Toronto; Krembil Research Institute (V.A.M.), Toronto Western Hospital, University Health Network; Department of Critical Care Medicine (V.A.M., D.C.S.), Sunnybrook Health Sciences Centre; Li Ka Shing Knowledge Institute (D.C.S.), St. Michael's Hospital, Toronto; Department of Medicine (B.R.), Division of Critical Care and Department of Health Research Methods, Evidence, and Impact (B.R.), McMaster University, Hamilton; and Institut du Savoir Montfort (K.K.), Ottawa, Ontario, Canada. .
Qureshi D; From the Division of Critical Care (S.M.F., S.W.E., K.K.), Department of Medicine, and Department of Emergency Medicine (S.M.F.), University of Ottawa; ICES (D.Q., R.T., M.M.S., D.C.S., P.T.), Toronto; Clinical Epidemiology Program (D.Q., R.T., D.D., M.M.S., S.W.E., P.T., K.K.), Ottawa Hospital Research Institute; School of Epidemiology and Public Health (D.Q., D.D., M.M.S., S.W.E., P.T.), University of Ottawa; Bruyère Research Institute (D.Q., P.T.); Division of Palliative Care (D.Q., P.T., K.K.), Department of Medicine, Division of Neurology (D.D.), Department of Medicine, and Division of Nephrology (M.M.S.), Department of Medicine, University of Ottawa, Ontario; Calgary Stroke Program (E.E.S., M.D.H.), Hotchkiss Brain Institute, and Department of Clinical Neurosciences (E.E.S., M.D.H.), Cumming School of Medicine, University of Calgary, Alberta; Interdepartmental Division of Critical Care Medicine (V.A.M., D.C.S.), University of Toronto; Krembil Research Institute (V.A.M.), Toronto Western Hospital, University Health Network; Department of Critical Care Medicine (V.A.M., D.C.S.), Sunnybrook Health Sciences Centre; Li Ka Shing Knowledge Institute (D.C.S.), St. Michael's Hospital, Toronto; Department of Medicine (B.R.), Division of Critical Care and Department of Health Research Methods, Evidence, and Impact (B.R.), McMaster University, Hamilton; and Institut du Savoir Montfort (K.K.), Ottawa, Ontario, Canada.
Talarico R; From the Division of Critical Care (S.M.F., S.W.E., K.K.), Department of Medicine, and Department of Emergency Medicine (S.M.F.), University of Ottawa; ICES (D.Q., R.T., M.M.S., D.C.S., P.T.), Toronto; Clinical Epidemiology Program (D.Q., R.T., D.D., M.M.S., S.W.E., P.T., K.K.), Ottawa Hospital Research Institute; School of Epidemiology and Public Health (D.Q., D.D., M.M.S., S.W.E., P.T.), University of Ottawa; Bruyère Research Institute (D.Q., P.T.); Division of Palliative Care (D.Q., P.T., K.K.), Department of Medicine, Division of Neurology (D.D.), Department of Medicine, and Division of Nephrology (M.M.S.), Department of Medicine, University of Ottawa, Ontario; Calgary Stroke Program (E.E.S., M.D.H.), Hotchkiss Brain Institute, and Department of Clinical Neurosciences (E.E.S., M.D.H.), Cumming School of Medicine, University of Calgary, Alberta; Interdepartmental Division of Critical Care Medicine (V.A.M., D.C.S.), University of Toronto; Krembil Research Institute (V.A.M.), Toronto Western Hospital, University Health Network; Department of Critical Care Medicine (V.A.M., D.C.S.), Sunnybrook Health Sciences Centre; Li Ka Shing Knowledge Institute (D.C.S.), St. Michael's Hospital, Toronto; Department of Medicine (B.R.), Division of Critical Care and Department of Health Research Methods, Evidence, and Impact (B.R.), McMaster University, Hamilton; and Institut du Savoir Montfort (K.K.), Ottawa, Ontario, Canada.
Dowlatshahi D; From the Division of Critical Care (S.M.F., S.W.E., K.K.), Department of Medicine, and Department of Emergency Medicine (S.M.F.), University of Ottawa; ICES (D.Q., R.T., M.M.S., D.C.S., P.T.), Toronto; Clinical Epidemiology Program (D.Q., R.T., D.D., M.M.S., S.W.E., P.T., K.K.), Ottawa Hospital Research Institute; School of Epidemiology and Public Health (D.Q., D.D., M.M.S., S.W.E., P.T.), University of Ottawa; Bruyère Research Institute (D.Q., P.T.); Division of Palliative Care (D.Q., P.T., K.K.), Department of Medicine, Division of Neurology (D.D.), Department of Medicine, and Division of Nephrology (M.M.S.), Department of Medicine, University of Ottawa, Ontario; Calgary Stroke Program (E.E.S., M.D.H.), Hotchkiss Brain Institute, and Department of Clinical Neurosciences (E.E.S., M.D.H.), Cumming School of Medicine, University of Calgary, Alberta; Interdepartmental Division of Critical Care Medicine (V.A.M., D.C.S.), University of Toronto; Krembil Research Institute (V.A.M.), Toronto Western Hospital, University Health Network; Department of Critical Care Medicine (V.A.M., D.C.S.), Sunnybrook Health Sciences Centre; Li Ka Shing Knowledge Institute (D.C.S.), St. Michael's Hospital, Toronto; Department of Medicine (B.R.), Division of Critical Care and Department of Health Research Methods, Evidence, and Impact (B.R.), McMaster University, Hamilton; and Institut du Savoir Montfort (K.K.), Ottawa, Ontario, Canada.
Sood MM; From the Division of Critical Care (S.M.F., S.W.E., K.K.), Department of Medicine, and Department of Emergency Medicine (S.M.F.), University of Ottawa; ICES (D.Q., R.T., M.M.S., D.C.S., P.T.), Toronto; Clinical Epidemiology Program (D.Q., R.T., D.D., M.M.S., S.W.E., P.T., K.K.), Ottawa Hospital Research Institute; School of Epidemiology and Public Health (D.Q., D.D., M.M.S., S.W.E., P.T.), University of Ottawa; Bruyère Research Institute (D.Q., P.T.); Division of Palliative Care (D.Q., P.T., K.K.), Department of Medicine, Division of Neurology (D.D.), Department of Medicine, and Division of Nephrology (M.M.S.), Department of Medicine, University of Ottawa, Ontario; Calgary Stroke Program (E.E.S., M.D.H.), Hotchkiss Brain Institute, and Department of Clinical Neurosciences (E.E.S., M.D.H.), Cumming School of Medicine, University of Calgary, Alberta; Interdepartmental Division of Critical Care Medicine (V.A.M., D.C.S.), University of Toronto; Krembil Research Institute (V.A.M.), Toronto Western Hospital, University Health Network; Department of Critical Care Medicine (V.A.M., D.C.S.), Sunnybrook Health Sciences Centre; Li Ka Shing Knowledge Institute (D.C.S.), St. Michael's Hospital, Toronto; Department of Medicine (B.R.), Division of Critical Care and Department of Health Research Methods, Evidence, and Impact (B.R.), McMaster University, Hamilton; and Institut du Savoir Montfort (K.K.), Ottawa, Ontario, Canada.
Smith EE; From the Division of Critical Care (S.M.F., S.W.E., K.K.), Department of Medicine, and Department of Emergency Medicine (S.M.F.), University of Ottawa; ICES (D.Q., R.T., M.M.S., D.C.S., P.T.), Toronto; Clinical Epidemiology Program (D.Q., R.T., D.D., M.M.S., S.W.E., P.T., K.K.), Ottawa Hospital Research Institute; School of Epidemiology and Public Health (D.Q., D.D., M.M.S., S.W.E., P.T.), University of Ottawa; Bruyère Research Institute (D.Q., P.T.); Division of Palliative Care (D.Q., P.T., K.K.), Department of Medicine, Division of Neurology (D.D.), Department of Medicine, and Division of Nephrology (M.M.S.), Department of Medicine, University of Ottawa, Ontario; Calgary Stroke Program (E.E.S., M.D.H.), Hotchkiss Brain Institute, and Department of Clinical Neurosciences (E.E.S., M.D.H.), Cumming School of Medicine, University of Calgary, Alberta; Interdepartmental Division of Critical Care Medicine (V.A.M., D.C.S.), University of Toronto; Krembil Research Institute (V.A.M.), Toronto Western Hospital, University Health Network; Department of Critical Care Medicine (V.A.M., D.C.S.), Sunnybrook Health Sciences Centre; Li Ka Shing Knowledge Institute (D.C.S.), St. Michael's Hospital, Toronto; Department of Medicine (B.R.), Division of Critical Care and Department of Health Research Methods, Evidence, and Impact (B.R.), McMaster University, Hamilton; and Institut du Savoir Montfort (K.K.), Ottawa, Ontario, Canada.
Hill MD; From the Division of Critical Care (S.M.F., S.W.E., K.K.), Department of Medicine, and Department of Emergency Medicine (S.M.F.), University of Ottawa; ICES (D.Q., R.T., M.M.S., D.C.S., P.T.), Toronto; Clinical Epidemiology Program (D.Q., R.T., D.D., M.M.S., S.W.E., P.T., K.K.), Ottawa Hospital Research Institute; School of Epidemiology and Public Health (D.Q., D.D., M.M.S., S.W.E., P.T.), University of Ottawa; Bruyère Research Institute (D.Q., P.T.); Division of Palliative Care (D.Q., P.T., K.K.), Department of Medicine, Division of Neurology (D.D.), Department of Medicine, and Division of Nephrology (M.M.S.), Department of Medicine, University of Ottawa, Ontario; Calgary Stroke Program (E.E.S., M.D.H.), Hotchkiss Brain Institute, and Department of Clinical Neurosciences (E.E.S., M.D.H.), Cumming School of Medicine, University of Calgary, Alberta; Interdepartmental Division of Critical Care Medicine (V.A.M., D.C.S.), University of Toronto; Krembil Research Institute (V.A.M.), Toronto Western Hospital, University Health Network; Department of Critical Care Medicine (V.A.M., D.C.S.), Sunnybrook Health Sciences Centre; Li Ka Shing Knowledge Institute (D.C.S.), St. Michael's Hospital, Toronto; Department of Medicine (B.R.), Division of Critical Care and Department of Health Research Methods, Evidence, and Impact (B.R.), McMaster University, Hamilton; and Institut du Savoir Montfort (K.K.), Ottawa, Ontario, Canada.
McCredie VA; From the Division of Critical Care (S.M.F., S.W.E., K.K.), Department of Medicine, and Department of Emergency Medicine (S.M.F.), University of Ottawa; ICES (D.Q., R.T., M.M.S., D.C.S., P.T.), Toronto; Clinical Epidemiology Program (D.Q., R.T., D.D., M.M.S., S.W.E., P.T., K.K.), Ottawa Hospital Research Institute; School of Epidemiology and Public Health (D.Q., D.D., M.M.S., S.W.E., P.T.), University of Ottawa; Bruyère Research Institute (D.Q., P.T.); Division of Palliative Care (D.Q., P.T., K.K.), Department of Medicine, Division of Neurology (D.D.), Department of Medicine, and Division of Nephrology (M.M.S.), Department of Medicine, University of Ottawa, Ontario; Calgary Stroke Program (E.E.S., M.D.H.), Hotchkiss Brain Institute, and Department of Clinical Neurosciences (E.E.S., M.D.H.), Cumming School of Medicine, University of Calgary, Alberta; Interdepartmental Division of Critical Care Medicine (V.A.M., D.C.S.), University of Toronto; Krembil Research Institute (V.A.M.), Toronto Western Hospital, University Health Network; Department of Critical Care Medicine (V.A.M., D.C.S.), Sunnybrook Health Sciences Centre; Li Ka Shing Knowledge Institute (D.C.S.), St. Michael's Hospital, Toronto; Department of Medicine (B.R.), Division of Critical Care and Department of Health Research Methods, Evidence, and Impact (B.R.), McMaster University, Hamilton; and Institut du Savoir Montfort (K.K.), Ottawa, Ontario, Canada.
Scales DC; From the Division of Critical Care (S.M.F., S.W.E., K.K.), Department of Medicine, and Department of Emergency Medicine (S.M.F.), University of Ottawa; ICES (D.Q., R.T., M.M.S., D.C.S., P.T.), Toronto; Clinical Epidemiology Program (D.Q., R.T., D.D., M.M.S., S.W.E., P.T., K.K.), Ottawa Hospital Research Institute; School of Epidemiology and Public Health (D.Q., D.D., M.M.S., S.W.E., P.T.), University of Ottawa; Bruyère Research Institute (D.Q., P.T.); Division of Palliative Care (D.Q., P.T., K.K.), Department of Medicine, Division of Neurology (D.D.), Department of Medicine, and Division of Nephrology (M.M.S.), Department of Medicine, University of Ottawa, Ontario; Calgary Stroke Program (E.E.S., M.D.H.), Hotchkiss Brain Institute, and Department of Clinical Neurosciences (E.E.S., M.D.H.), Cumming School of Medicine, University of Calgary, Alberta; Interdepartmental Division of Critical Care Medicine (V.A.M., D.C.S.), University of Toronto; Krembil Research Institute (V.A.M.), Toronto Western Hospital, University Health Network; Department of Critical Care Medicine (V.A.M., D.C.S.), Sunnybrook Health Sciences Centre; Li Ka Shing Knowledge Institute (D.C.S.), St. Michael's Hospital, Toronto; Department of Medicine (B.R.), Division of Critical Care and Department of Health Research Methods, Evidence, and Impact (B.R.), McMaster University, Hamilton; and Institut du Savoir Montfort (K.K.), Ottawa, Ontario, Canada.
English SW; From the Division of Critical Care (S.M.F., S.W.E., K.K.), Department of Medicine, and Department of Emergency Medicine (S.M.F.), University of Ottawa; ICES (D.Q., R.T., M.M.S., D.C.S., P.T.), Toronto; Clinical Epidemiology Program (D.Q., R.T., D.D., M.M.S., S.W.E., P.T., K.K.), Ottawa Hospital Research Institute; School of Epidemiology and Public Health (D.Q., D.D., M.M.S., S.W.E., P.T.), University of Ottawa; Bruyère Research Institute (D.Q., P.T.); Division of Palliative Care (D.Q., P.T., K.K.), Department of Medicine, Division of Neurology (D.D.), Department of Medicine, and Division of Nephrology (M.M.S.), Department of Medicine, University of Ottawa, Ontario; Calgary Stroke Program (E.E.S., M.D.H.), Hotchkiss Brain Institute, and Department of Clinical Neurosciences (E.E.S., M.D.H.), Cumming School of Medicine, University of Calgary, Alberta; Interdepartmental Division of Critical Care Medicine (V.A.M., D.C.S.), University of Toronto; Krembil Research Institute (V.A.M.), Toronto Western Hospital, University Health Network; Department of Critical Care Medicine (V.A.M., D.C.S.), Sunnybrook Health Sciences Centre; Li Ka Shing Knowledge Institute (D.C.S.), St. Michael's Hospital, Toronto; Department of Medicine (B.R.), Division of Critical Care and Department of Health Research Methods, Evidence, and Impact (B.R.), McMaster University, Hamilton; and Institut du Savoir Montfort (K.K.), Ottawa, Ontario, Canada.
Rochwerg B; From the Division of Critical Care (S.M.F., S.W.E., K.K.), Department of Medicine, and Department of Emergency Medicine (S.M.F.), University of Ottawa; ICES (D.Q., R.T., M.M.S., D.C.S., P.T.), Toronto; Clinical Epidemiology Program (D.Q., R.T., D.D., M.M.S., S.W.E., P.T., K.K.), Ottawa Hospital Research Institute; School of Epidemiology and Public Health (D.Q., D.D., M.M.S., S.W.E., P.T.), University of Ottawa; Bruyère Research Institute (D.Q., P.T.); Division of Palliative Care (D.Q., P.T., K.K.), Department of Medicine, Division of Neurology (D.D.), Department of Medicine, and Division of Nephrology (M.M.S.), Department of Medicine, University of Ottawa, Ontario; Calgary Stroke Program (E.E.S., M.D.H.), Hotchkiss Brain Institute, and Department of Clinical Neurosciences (E.E.S., M.D.H.), Cumming School of Medicine, University of Calgary, Alberta; Interdepartmental Division of Critical Care Medicine (V.A.M., D.C.S.), University of Toronto; Krembil Research Institute (V.A.M.), Toronto Western Hospital, University Health Network; Department of Critical Care Medicine (V.A.M., D.C.S.), Sunnybrook Health Sciences Centre; Li Ka Shing Knowledge Institute (D.C.S.), St. Michael's Hospital, Toronto; Department of Medicine (B.R.), Division of Critical Care and Department of Health Research Methods, Evidence, and Impact (B.R.), McMaster University, Hamilton; and Institut du Savoir Montfort (K.K.), Ottawa, Ontario, Canada.
Tanuseputro P; From the Division of Critical Care (S.M.F., S.W.E., K.K.), Department of Medicine, and Department of Emergency Medicine (S.M.F.), University of Ottawa; ICES (D.Q., R.T., M.M.S., D.C.S., P.T.), Toronto; Clinical Epidemiology Program (D.Q., R.T., D.D., M.M.S., S.W.E., P.T., K.K.), Ottawa Hospital Research Institute; School of Epidemiology and Public Health (D.Q., D.D., M.M.S., S.W.E., P.T.), University of Ottawa; Bruyère Research Institute (D.Q., P.T.); Division of Palliative Care (D.Q., P.T., K.K.), Department of Medicine, Division of Neurology (D.D.), Department of Medicine, and Division of Nephrology (M.M.S.), Department of Medicine, University of Ottawa, Ontario; Calgary Stroke Program (E.E.S., M.D.H.), Hotchkiss Brain Institute, and Department of Clinical Neurosciences (E.E.S., M.D.H.), Cumming School of Medicine, University of Calgary, Alberta; Interdepartmental Division of Critical Care Medicine (V.A.M., D.C.S.), University of Toronto; Krembil Research Institute (V.A.M.), Toronto Western Hospital, University Health Network; Department of Critical Care Medicine (V.A.M., D.C.S.), Sunnybrook Health Sciences Centre; Li Ka Shing Knowledge Institute (D.C.S.), St. Michael's Hospital, Toronto; Department of Medicine (B.R.), Division of Critical Care and Department of Health Research Methods, Evidence, and Impact (B.R.), McMaster University, Hamilton; and Institut du Savoir Montfort (K.K.), Ottawa, Ontario, Canada.
Kyeremanteng K; From the Division of Critical Care (S.M.F., S.W.E., K.K.), Department of Medicine, and Department of Emergency Medicine (S.M.F.), University of Ottawa; ICES (D.Q., R.T., M.M.S., D.C.S., P.T.), Toronto; Clinical Epidemiology Program (D.Q., R.T., D.D., M.M.S., S.W.E., P.T., K.K.), Ottawa Hospital Research Institute; School of Epidemiology and Public Health (D.Q., D.D., M.M.S., S.W.E., P.T.), University of Ottawa; Bruyère Research Institute (D.Q., P.T.); Division of Palliative Care (D.Q., P.T., K.K.), Department of Medicine, Division of Neurology (D.D.), Department of Medicine, and Division of Nephrology (M.M.S.), Department of Medicine, University of Ottawa, Ontario; Calgary Stroke Program (E.E.S., M.D.H.), Hotchkiss Brain Institute, and Department of Clinical Neurosciences (E.E.S., M.D.H.), Cumming School of Medicine, University of Calgary, Alberta; Interdepartmental Division of Critical Care Medicine (V.A.M., D.C.S.), University of Toronto; Krembil Research Institute (V.A.M.), Toronto Western Hospital, University Health Network; Department of Critical Care Medicine (V.A.M., D.C.S.), Sunnybrook Health Sciences Centre; Li Ka Shing Knowledge Institute (D.C.S.), St. Michael's Hospital, Toronto; Department of Medicine (B.R.), Division of Critical Care and Department of Health Research Methods, Evidence, and Impact (B.R.), McMaster University, Hamilton; and Institut du Savoir Montfort (K.K.), Ottawa, Ontario, Canada.
Pokaż więcej
Źródło :
Neurology [Neurology] 2021 Aug 10; Vol. 97 (6), pp. e608-e618. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anticoagulants*/administration & dosage
Anticoagulants*/economics
Anticoagulants*/therapeutic use
Cerebral Hemorrhage*/economics
Cerebral Hemorrhage*/epidemiology
Cerebral Hemorrhage*/therapy
Facilities and Services Utilization*/economics
Facilities and Services Utilization*/statistics & numerical data
Health Care Costs*/statistics & numerical data
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Ontario/epidemiology ; Outcome Assessment, Health Care ; Respiration, Artificial/economics ; Respiration, Artificial/statistics & numerical data ; Retrospective Studies ; Time Factors
Czasopismo naukowe
Tytuł :
The Clinical Significance of Drug-Food Interactions of Direct Oral Anticoagulants.
Autorzy :
Grześk G; Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Ujejskiego 75 Street, 85-168 Bydgoszcz, Poland.
Rogowicz D; Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Ujejskiego 75 Street, 85-168 Bydgoszcz, Poland.
Wołowiec Ł; Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Ujejskiego 75 Street, 85-168 Bydgoszcz, Poland.
Ratajczak A; Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Ujejskiego 75 Street, 85-168 Bydgoszcz, Poland.
Gilewski W; Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Ujejskiego 75 Street, 85-168 Bydgoszcz, Poland.
Chudzińska M; Department of Nutrition and Dietetics, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Dębowa 3 Street, 85-626 Bydgoszcz, Poland.
Sinkiewicz A; Department of Otolaryngology, Audiology and Phoniatrics, University Hospital No. 2, Collegium Medicum, Nicolaus Copernicus University in Toruń, Ujejskiego 75 Street, 85-168 Bydgoszcz, Poland.
Banach J; Department of Cardiology and Clinical Pharmacology, Faculty of Health Sciences, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Ujejskiego 75 Street, 85-168 Bydgoszcz, Poland.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Aug 08; Vol. 22 (16). Date of Electronic Publication: 2021 Aug 08.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anticoagulants*/pharmacokinetics
Anticoagulants*/therapeutic use
Dietary Supplements*
Food-Drug Interactions*
Vitamin K*/antagonists & inhibitors
Vitamin K*/blood
Administration, Oral ; Humans
Czasopismo naukowe
Tytuł :
Regional citrate anticoagulation protocol suitable for intermittent hemodialysis and post-dilution hemodiafiltration.
Autorzy :
Goet E
Wentz B
Frank RD
Pokaż więcej
Źródło :
Clinical nephrology [Clin Nephrol] 2021 Aug; Vol. 96 (2), pp. 90-95.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants*/administration & dosage
Anticoagulants*/therapeutic use
Citric Acid*/administration & dosage
Citric Acid*/therapeutic use
Hemodiafiltration/*methods
Renal Dialysis/*methods
Hemorrhage/prevention & control ; Humans ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Post-hospital discharge venous thromboembolism prophylaxis in medically ill patients.
Autorzy :
Berkman SA; Department of medicine, Division of hematology/Oncology UCLA, California.
Pokaż więcej
Źródło :
Postgraduate medicine [Postgrad Med] 2021 Aug; Vol. 133 (sup1), pp. 51-63. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anticoagulants*/classification
Anticoagulants*/pharmacology
COVID-19*/blood
COVID-19*/complications
COVID-19*/therapy
Venous Thromboembolism*/etiology
Venous Thromboembolism*/prevention & control
Chemoprevention/*methods
Aftercare/methods ; Clinical Trials as Topic ; Humans ; Patient Discharge ; Risk Adjustment ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Randomized clinical trial to evaluate a routine full anticoagulation Strategy in Patients with Coronavirus Infection (SARS-CoV2) admitted to hospital: Rationale and design of the ACTION (AntiCoagulaTlon cOroNavirus)-Coalition IV trial.
Autorzy :
Lopes RD; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC; Brazilian Clinical Research Institute, São Paulo, Brazil. Electronic address: .
de Barros E Silva PGM; Brazilian Clinical Research Institute, São Paulo, Brazil; HCOR Research Institute, São Paulo, Brazil; Hospital Samaritano Paulista, São Paulo, Brazil.
Furtado RHM; Academic Research Organization, Hospital Israelita Albert Einstein, São Paulo, Brazil; Instituto do Coração (InCor), Hospital das Clinicas da Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazill.
Macedo AVS; Brazilian Clinical Research Institute, São Paulo, Brazil.
Ramacciotti E; Brazilian Clinical Research Institute, São Paulo, Brazil.
Damini LP; Brazilian Clinical Research Institute, São Paulo, Brazil; HCOR Research Institute, São Paulo, Brazil.
Bronhara B; Brazilian Clinical Research Institute, São Paulo, Brazil.
Cavalcanti AB; HCOR Research Institute, São Paulo, Brazil; Brazilian Research in Intensive Care Network-BRICNet, São Paulo, Brazil.
Rosa RG; Hospital Moinhos de Vento, Porto Alegre, Brazil; Hospital Sírio Libanês Research and Education Institute, São Paulo, Brazil.
Azevedo LCP; Hospital Moinhos de Vento, Porto Alegre, Brazil; Hospital Sírio Libanês Research and Education Institute, São Paulo, Brazil.
Veiga VC; Hospital Moinhos de Vento, Porto Alegre, Brazil; BP-A Beneficência Portuguesa de São Paulo, São Paulo, Brazil.
Machado FR; Hospital Moinhos de Vento, Porto Alegre, Brazil; Federal University of São Paulo (UNIFES), Paulista School of Medicine (EPM), São Paulo, Brazil.
Ritt LE; Hospital Cardio-Pulmonar, Salvador, Brazil; Escola Bahiana de Medicina, Salvador, Brazil.
Martins PA; Hospital Estadual Dr Jayme Santos Neves, Serra, Brazil.
Alexander JH; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC.
Avezum A; International Research Center, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
Berwanger O; Academic Research Organization, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Pokaż więcej
Corporate Authors :
Coalition COVID-19 Brazil IV Investigators
Źródło :
American heart journal [Am Heart J] 2021 Aug; Vol. 238, pp. 1-11. Date of Electronic Publication: 2021 Apr 20.
Typ publikacji :
Clinical Trial Protocol; Clinical Trial, Phase IV; Journal Article; Multicenter Study; Pragmatic Clinical Trial; Randomized Controlled Trial
MeSH Terms :
Anticoagulants/*therapeutic use
COVID-19/*complications
Enoxaparin/*therapeutic use
Rivaroxaban/*therapeutic use
Thrombosis/*prevention & control
Administration, Oral ; Anticoagulants/administration & dosage ; Anticoagulants/adverse effects ; Brazil ; COVID-19/blood ; COVID-19/mortality ; Drug Administration Schedule ; Enoxaparin/administration & dosage ; Enoxaparin/adverse effects ; Fibrin Fibrinogen Degradation Products/analysis ; Hemorrhage/chemically induced ; Hospitalization ; Humans ; Oxygen Inhalation Therapy ; Rivaroxaban/administration & dosage ; Rivaroxaban/adverse effects ; Thrombosis/etiology ; Time Factors
Czasopismo naukowe
Tytuł :
Personalized prophylactic anticoagulation in hospitalized patients with Covid-19 - The role of anti-Xa monitoring.
Autorzy :
Kofteridis DP; Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, Crete, Greece. Electronic address: .
Ioannou P; Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, Crete, Greece.
Kondili E; Intensive Care Unit, University Hospital of Heraklion, Heraklion, Crete, Greece.
Chamilos G; Department of Clinical Microbiology and Microbial Pathogenesis, University Hospital of Heraklion, Heraklion, Crete, Greece.
Filippatos TD; Department of Internal Medicine & Infectious Diseases, University Hospital of Heraklion, Heraklion, Crete, Greece.
Pokaż więcej
Źródło :
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2021 Aug; Vol. 27 (8), pp. 1188-1189. Date of Electronic Publication: 2021 Apr 29.
Typ publikacji :
Letter
MeSH Terms :
Anticoagulants/*administration & dosage
COVID-19/*drug therapy
COVID-19/*prevention & control
Factor Xa Inhibitors/*blood
Hospitalization/*statistics & numerical data
Monitoring, Physiologic/*methods
Aged ; Anticoagulants/blood ; Anticoagulants/therapeutic use ; COVID-19/blood ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; SARS-CoV-2/drug effects
Opinia redakcyjna
Tytuł :
Comparison of 3 Different Prothrombin Complex Concentrate Regimens for Emergent Warfarin Reversal: PCCWaR Study.
Autorzy :
Dietrich SK; University of Colorado Health-North, Fort Collins, CO, USA.
Rowe S; The University of Tennessee Health Sciences Center, Knoxville, TN, USA.
Cocchio CA; CHRISTUS Mother Frances Hospital, Tyler, TX, USA.
Harmon AJ; St Joseph's Hospital, Tampa, FL, USA.
Nerenberg SF; St Joseph's University Medical Center, Paterson, NJ, USA.
Blankenship PS; Blount Memorial Hospital, Maryville, TN, USA.
Pokaż więcej
Źródło :
The Annals of pharmacotherapy [Ann Pharmacother] 2021 Aug; Vol. 55 (8), pp. 980-987. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Anticoagulants*/adverse effects
Warfarin*/adverse effects
Blood Coagulation Factors ; Humans ; International Normalized Ratio ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Affinity ultrafiltration and UPLC-HR-Orbitrap-MS based screening of thrombin-targeted small molecules with anticoagulation activity from Poecilobdella manillensis.
Autorzy :
Huang Q; School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China.
Tang J; Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
Chai X; School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China.
Ren W; Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China.
Wang J; School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China.
Gan Q; Chongqing Duoputai Pharmaceutical Co., Ltd, Chongqing 400800, China.
Shi J; Chongqing Duoputai Pharmaceutical Co., Ltd, Chongqing 400800, China.
Wang M; School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China.
Yang S; Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China.
Liu J; Public Technology Service Center, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.
Ma L; School of Traditional Chinese Medicine, Capital Medical University, Beijing 100069, China. Electronic address: .
Pokaż więcej
Źródło :
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2021 Jul 15; Vol. 1178, pp. 122822. Date of Electronic Publication: 2021 Jun 08.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants*/chemistry
Anticoagulants*/isolation & purification
Anticoagulants*/metabolism
Biological Products*/chemistry
Biological Products*/isolation & purification
Biological Products*/metabolism
Leeches/*chemistry
Thrombin/*metabolism
Ultrafiltration/*methods
Animals ; Chromatography, High Pressure Liquid/methods ; Mass Spectrometry/methods ; Molecular Docking Simulation
Czasopismo naukowe
Tytuł :
Preceding direct oral anticoagulant administration reduces the severity of stroke in patients with atrial fibrillation - K-PLUS registry.
Autorzy :
Nakajima M; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. Electronic address: .
Inatomi Y; Department of Neurology, Saiseikai Kumamoto Hospital, Japan. Electronic address: .
Ueda A; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. Electronic address: .
Ito Y; Department of Neurology, Minamata City General Hospital & Medical Center, Minamata, Japan.
Kouzaki Y; Department of Neurology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Takita T; Department of Neurology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
Wada K; Department of Neurology, Kumamoto City Hospital, Kumamoto, Japan. Electronic address: .
Yonehara T; Department of Neurology, Saiseikai Kumamoto Hospital, Japan. Electronic address: .
Terasaki T; Department of Neurology, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan. Electronic address: .
Hashimoto Y; Department of Neurology, Kumamoto City Hospital, Kumamoto, Japan. Electronic address: .
Ando Y; Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Department of Amyloidosis, Nagasaki International University, Sasebo, Japan. Electronic address: .
Pokaż więcej
Źródło :
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia [J Clin Neurosci] 2021 Jul; Vol. 89, pp. 106-112. Date of Electronic Publication: 2021 May 06.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Anticoagulants/*administration & dosage
Atrial Fibrillation/*complications
Fibrinolytic Agents/*administration & dosage
Ischemic Stroke/*drug therapy
Warfarin/*administration & dosage
Administration, Oral ; Aged ; Aged, 80 and over ; Anticoagulants/therapeutic use ; Fibrinolytic Agents/therapeutic use ; Humans ; Ischemic Stroke/etiology ; Ischemic Stroke/prevention & control ; Middle Aged ; Warfarin/therapeutic use
Czasopismo naukowe
Tytuł :
Anticoagulation in Elective Spine Cases: Rates of Hematomas Versus Thromboembolic Disease.
Autorzy :
Thota DR; The University of Texas Southwestern Medical Center, Dallas, Texas.
Bagley CA
Tamimi MA
Nakonezny PA
Van Hal M
Pokaż więcej
Źródło :
Spine [Spine (Phila Pa 1976)] 2021 Jul 01; Vol. 46 (13), pp. 901-906.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants*/adverse effects
Anticoagulants*/therapeutic use
Elective Surgical Procedures*/adverse effects
Elective Surgical Procedures*/methods
Hematoma*/epidemiology
Hematoma*/etiology
Orthopedic Procedures*/adverse effects
Orthopedic Procedures*/methods
Spine/*surgery
Humans ; Incidence ; Reoperation ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Review of coagulation preanalytical variables with update on the effect of direct oral anticoagulants.
Autorzy :
Gosselin RC; Hemostasis & Thrombosis Center, Davis Health System, University of California, Sacramento, CA, USA.
Pokaż więcej
Źródło :
International journal of laboratory hematology [Int J Lab Hematol] 2021 Jul; Vol. 43 Suppl 1, pp. 109-116.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Blood Coagulation Tests*
Anticoagulants/*administration & dosage
Blood Coagulation/*drug effects
Administration, Oral ; Anticoagulants/therapeutic use ; Blood Coagulation Disorders/blood ; Blood Coagulation Disorders/diagnosis ; Blood Coagulation Disorders/etiology ; Blood Coagulation Disorders/therapy ; Humans ; Partial Thromboplastin Time ; Phlebotomy ; Prothrombin Time ; Specimen Handling/methods ; Specimen Handling/standards ; Time Factors
Czasopismo naukowe
Tytuł :
Marine sulfated polysaccharides as potential antiviral drug candidates to treat Corona Virus disease (COVID-19).
Autorzy :
Andrew M; Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India.
Jayaraman G; Department of Biotechnology, School of Biosciences and Technology, Vellore Institute of Technology, Vellore, 632014, Tamil Nadu, India. Electronic address: .
Pokaż więcej
Źródło :
Carbohydrate research [Carbohydr Res] 2021 Jul; Vol. 505, pp. 108326. Date of Electronic Publication: 2021 May 03.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anticoagulants/*therapeutic use
Antiviral Agents/*therapeutic use
COVID-19/*drug therapy
Immunologic Factors/*therapeutic use
Polysaccharides/*therapeutic use
Pulmonary Embolism/*drug therapy
Respiratory Insufficiency/*drug therapy
Anticoagulants/chemistry ; Anticoagulants/isolation & purification ; Antiviral Agents/chemistry ; Antiviral Agents/isolation & purification ; Blood Platelets/drug effects ; Blood Platelets/pathology ; Blood Platelets/virology ; COVID-19/complications ; COVID-19/diagnosis ; COVID-19/virology ; Humans ; Immunologic Factors/chemistry ; Immunologic Factors/isolation & purification ; Lung/blood supply ; Lung/drug effects ; Lung/pathology ; Lung/virology ; Phaeophyta/chemistry ; Polysaccharides/chemistry ; Polysaccharides/isolation & purification ; Pulmonary Embolism/complications ; Pulmonary Embolism/diagnosis ; Pulmonary Embolism/virology ; Respiratory Insufficiency/complications ; Respiratory Insufficiency/diagnosis ; Respiratory Insufficiency/virology ; Rhodophyta/chemistry ; SARS-CoV-2/drug effects ; SARS-CoV-2/pathogenicity ; Sulfuric Acid Esters/chemistry ; Virus Attachment/drug effects ; Virus Internalization/drug effects
Czasopismo naukowe
Tytuł :
Comparison of multivariate linear regression and a machine learning algorithm developed for prediction of precision warfarin dosing in a Korean population.
Autorzy :
Nguyen VL; Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Korea.
Nguyen HD; Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Korea.
Cho YS; Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Korea.
Kim HS; Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Korea.
Han IY; Department of Thoracic and Cardiovascular Surgery, Inje University Busan Paik Hospital, Busan, Korea.
Kim DK; Division of Cardiology, Department of Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea.
Ahn S; Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Korea.
Shin JG; Department of Pharmacology and Pharmacogenomics Research Center, Inje University College of Medicine, Busan, Korea.; Center for Personalized Precision Medicine of Tuberculosis, Inje University College of Medicine, Busan, Korea.; Department of Clinical Pharmacology, Inje University Bsuan Paik Hospital, Busan, Korea.
Pokaż więcej
Źródło :
Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Jul; Vol. 19 (7), pp. 1676-1686. Date of Electronic Publication: 2021 Apr 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anticoagulants*
Warfarin*
Algorithms ; Cohort Studies ; Cytochrome P-450 CYP2C9/genetics ; Genotype ; Humans ; Linear Models ; Machine Learning ; Republic of Korea ; Vitamin K Epoxide Reductases/genetics
Czasopismo naukowe
Tytuł :
The Impact of Traditional Anticoagulants, Novel Anticoagulants, and Antiplatelets on Epistaxis.
Autorzy :
Yaniv D; Department of Otolaryngology -Head and neck Surgery, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Zavdy O; Department of Otolaryngology -Head and neck Surgery, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sapir E; Department of Otolaryngology -Head and neck Surgery, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Levi L; Department of Otolaryngology -Head and neck Surgery, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Soudry E; Department of Otolaryngology -Head and neck Surgery, Rabin Medical Center, Petah Tikva, Israel.; Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Pokaż więcej
Źródło :
The Laryngoscope [Laryngoscope] 2021 Sep; Vol. 131 (9), pp. 1946-1951. Date of Electronic Publication: 2021 Feb 03.
Typ publikacji :
Journal Article
MeSH Terms :
Anticoagulants/*adverse effects
Epistaxis/*chemically induced
Factor Xa Inhibitors/*adverse effects
Platelet Aggregation Inhibitors/*adverse effects
Warfarin/*adverse effects
Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Anticoagulants/administration & dosage ; Case-Control Studies ; Enoxaparin/adverse effects ; Epistaxis/diagnosis ; Female ; Hospitalization/statistics & numerical data ; Humans ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Platelet Aggregation Inhibitors/administration & dosage ; Recurrence ; Retrospective Studies ; Safety ; Severity of Illness Index ; Warfarin/administration & dosage
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies